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Vasculogenesis and angiogenesis, the fundamental processes by which new blood vessels 
are formed, involve the proliferation, migration, and remodeling of endothelial cells. 
Dynamic adhesion of endothelial cells to extracellular matrix plays a fundamental role in 
all these events. Key regulators of endothelial cells adhesion and migration are the αvβ3 
and uPA-uPAR complexes. The αvβ3 integrin heterodimer is the receptor for 
extracellular matrix components such as vitronectin and is overexpressed on the cell 
surface of angiogenic endothelial cells, but not quiescent cells lining normal vessels. The 
uPA-uPAR complex contributes to extracellular matrix remodelling by mediating 
proteolytic activity at the leading edge of migrating cells. We recently reported that the 
FOSL1 transcription factor of the AP-1 family plays a pivotal role in the regulation of the 
level of the αvβ3 and uPA-uPAR complexes on the surface of endothelial cells. In this 
commentary, we review the current knowledge of αv and β3 transcriptional regulation in 
endothelial cells and discuss the role of FOSL1 in angiogenesis.  
 
 
Angiogenesis is a crucial process during embryonic development and physiological tissue 
homeostasis and repair in the adult. On the other hand, pathological angiogenesis is 
  
frequently implicated in diseases, including cancer, rheumatoid arthritis, diabetic 
retinopathy and age-related macular degeneration. During this process, endothelial cells 
proliferation and migration lead the sprout of new blood vessels from pre-existing ones 
and regulation of endothelial cell adhesion to extracellular matrix (ECM) is particularly 
important. Integrins are heterodimeric transmembrane receptors that bind ECM proteins 
such as fibronectin, laminins, collagens and vitronectin. Functional integrins are non-
covalent heterodimeric complexes composed of paired α and β subunits. In humans, 18 α 
and 8 β different subunits can combine to form dimers with variable specificity of 
binding to one or more ECM components.1 Ligand binding triggers integrins 
conformational changes and consequent activation of specific cytoplasmic signaling 
pathways.1,2 
Whereas many integrins are ubiquitously expressed in adult tissues, αvβ3 and α5β1 
integrins are expressed at higher levels on the cell surface of activated endothelial cells in 
physiological and pathological angiogenesis, but not in normal quiescent vessels,3,4 
similarly to what has been observed for the vascular endothelial growth factor receptor-3 
(VEGFR-3)5-7 which is induced in endothelial cells undergoing new vessel sprouting. 
These features render αvβ3 and α5β1 integrins promising targets for pharmaceutical 
inhibition of pathological angiogenesis. 
Despite the growing interest for anti-angiogenic therapies based on integrin αvβ3 
antagonism, the molecular mechanisms for the transcriptional regulation of these subunits 
are not fully understood. The potent angiogenic growth factor bFGF promotes the 
conversion of endothelium from resting to its active angiogenic state and this action is 
mediated, at least in part, by the induction of the homeobox transcription factor HOX D3. 
Boudreau and colleagues demonstrated that HOX D3 binds directly to the promoters of 
the α5 and β3 integrin subunits, inducing their expression.8,9 The binding of HOX D3 to 
target DNA is enhanced by PBX1, a transcription co-factor expressed at higher levels in 
activated angiogenic endothelial cells and it is required for angiogenesis induced by 
bFGF.10 Forkhead transcription factor FOXC2 is another essential regulator of blood and 
lymphatic vessels formation.11,12 In particular, FOXC2 positively regulates endothelial 
cell migration and adhesion by binding directly to multiple Forkhead-binding elements 
within two homology regions in the integrin β3 promoter and inducing its expression.11 
The human promoters of αv and β3 subunits contain GGA/TCC repeats and GC rich 
sequences, which are binding sites for the ubiquitous transcription factor SP1.13-15 By 
chromatin immunoprecipitation (ChIP) we recently demonstrated that SP1 actually binds 
to both αv and β3 promoters.16 
Similarly to other members of the AP-1 transcription factor family, which are required 
for endothelial cell survival,17 FOSL1 (FOS-Like1; also named FRA1), was supposed to 
play a role in angiogenesis because its mouse hortologue Fosl1 has been previously 
shown to be required for the correct vascularization of extra-embryonic tissues.18 In a 
mouse model of embryonic development in vitro, we demonstrated that Fosl1-/- 
embryonic stem cells maintain the capacity to differentiate in endothelial cells but fail to 
correctly assemble and form disorganized vessel-like structures. Human primary 
umbilical vein endothelial cells (HUVEC) silenced for FOSL1 expression displayed 
similar features, and they failed to form in vitro capillary-like structures. By gene 
expression profile we found that FOSL1-silenced HUVEC overexpressed the αv and β3 
  
integrin subunits. We demonstrated that endogenous FOSL1 binds to the promoters of 
both integrin subunits repressing their gene expression. This effect is possibly mediated 
by epigenetic mechanisms, since FOSL1 binding to these promoters induces the 
deacetylation of histone H4 at lysine 16. 
As a consequence of αv and β3 overexpression, endothelial cells knockdown for FOSL1   
showed decreased migration and increased adhesion on vitronectin. At the morphological 
level, the focal adhesions and the actin stress fibers were not aligned in the direction of 
cell migration but randomly distributed. Focal adhesions are comprised of clusters of 
integrin receptors associated with large complexes of structural and signaling proteins 
linked to the actin cytoskeleton. Integrins in the focal adhesions have the structural 
function to connect actin stress fibers to the ECM and a signaling function to regulate the 
organization of the actin cytoskeleton as well. The constant remodeling of the actin stress 
fibers and the rapid assembly/disassembly of the focal adhesions are essential for 
endothelial cell migration, which requires continuous adhesion/de-adhesion processes. In 
this coordinated process, integrins must disengage from ECM contacts at the trailing end 
and form new focal contacts at the leading edge. Thus, dysregulation of αvβ3 integrin 
complex in FOSL1-silenced cells results in the increased size and stabilization of focal 
adhesions with the consequent increased cell adhesion and inhibition of migration. This 
was confirmed by lentiviral vector-mediated over-expression of αvβ3 integrin, that 
showed phenotypic alterations similar to those obtained by FOSL1 silencing, thus 
suggesting that the expression of FOSL1 controlling the level of αvβ3 integrin complex 
is crucial for functional focal contacts, cytoskeleton organization, and migration. 
 
FOSL1 is a basic-leucine zipper (bZIP) protein that must dimerize with proteins of the 
JUN family to form the active transcription factor complex AP-1. Using ChIP assay, we 
demonstrated that JUND binds to both αv and β3 promoters in a FOSL1-dependent 
manner suggesting that JUND is the heterodimeric binding partner of FOSL1 on these 
promoters. However, no AP-1 binding sites are present in αv and β3 promoters. Indeed, 
we found that FOSL1 binds on αv and β3 promoters trough its interaction with the 
nuclear factor SP1 (Figure 1), similarly to what happens with the v-Jun homodimer on 
the SPARC promoter.19 Interestingly, in both cases the indirect binding of an AP-1 factor 
through SP1 act as a repressor of the transcription. 
 
Endothelial cells migration also requires ECM proteolysis and remodeling. Besides αvβ3 
integrin, we also identified uPA and uPAR as FOSL1-regulated genes in endothelial cells. 
In this case FOSL1 promotes their expression (Figure 2).16 The urokinase receptor 
(uPAR) is a specific receptor for the serine protease urokinase plasminogen activator 
(uPA). The uPA-uPAR complex is exposed at the cell surface and contributes to ECM 
remodelling by directing proteolytic activity at the leading edge of migrating cells.20 In 
addition to its central role in ECM proteolysis, the uPA-uPAR complex acts as a co-
receptor of integrins and is important for their activation and redistribution during focal 
adhesion turnover.21,22 In fact, uPA-uPAR complex has been shown to interact with 
vitronectin and is required to activate αvβ3 integrin in podocytes, promoting cell 
migration.23,24 
  
Upon bFGF treatment, which promotes endothelial cells activation, endothelial cells 
respond with the induction of αvβ3 complex and uPA,8 but also with the activation of 
FOSL1.25 Our results are compatible with a model in which FOSL1 functions as a 
modulator of both complexes to precisely tuning the level of key molecules on 
endothelial cell surface. FOSL1 can function as either an activator or a repressor, 
depending on the gene-context, controlling in this way the delicate equilibrium between 
adhesion and migration in ongoing angiogenesis. 
In conclusion, while more information is available about β3 regulation, very little is 
known about transcription factors directly regulating αv integrin in any cell types. 
Our group has demonstrated that FOSL1 is a direct down-modulator of both αv and β3 
integrin subunits in activated endothelial cells, but given that this complex is a worthy 
candidate for anti-angiogenic therapy in cancer, it will be interesting also to determine the 
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Legend to Figures 
 
Figure 1. Schematic representation of FOSL1 binding and negative regulation of the αv 
and β3 promoters in endothelial cells. The heterodimer FOSL1/JUND binds promoters 
DNA through SP1 and recruits histone deacetylase complex to repress trascription. Green 
flags represent acetyl groups on H4K16.  
 
Figure 2. Expression level of uPA and uPAR mRNAs in HUVEC silenced for FOSL1 
and in FOSL1-silenced cells infected with a viral vector expressing an shRNA-resistant 
FOSL1 mutant (rescue). Resultes were normalized to glyceraldehyde-3-phsphate 
dehydrogenase (GAPDH) mRNA. Mean values from three independent experiments are 
shown. Standard deviations are indicated.  
 
 


